Core Laboratories (Core Laboratories) EBIT per Share : $1.03 (TTM As of Mar. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Core Laboratories EBIT per Share?

Core Laboratories's EBIT per Share for the three months ended in Mar. 2023 was $0.14. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $1.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Core Laboratories's EBIT per Share or its related term are showing as below:

CLB's 3-Year EBIT Growth Rate is not ranked ^*
in the Oil & Gas industry.
Industry Median: 20.6
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Core Laboratories's EBIT for the three months ended in Mar. 2023 was $6.5 Mil.

Core Laboratories EBIT per Share Historical Data

The historical data trend for Core Laboratories's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Laboratories EBIT per Share Chart

Core Laboratories Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

2.67

2.17

-1.73

0.97

0.89

Core Laboratories Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EBIT per Share	Get a 7-Day Free Trial															-0.01	0.25	0.31	0.34	0.14

Core Laboratories EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Core Laboratories's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	41.524	/	46.813
=	0.89

Core Laboratories's EBIT per Share for the quarter that ended in Mar. 2023 is calculated as

	EBIT per Share		(Q: Mar. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	6.481	/	47.481
=	0.14

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.03

Core Laboratories (NYSE:CLB) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Core Laboratories EBIT per Share Related Terms

Thank you for viewing the detailed overview of Core Laboratories's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Core Laboratories (Core Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Core Laboratories Inc (NYSE:CLB) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

6316 Windfern Road, Houston, TX, USA, 77040

Website

https://www.corelab.com

Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Executives

Katherine Murray	director	6316 WINDFERN ROAD, HOUSTON TX 77040
Mark Damian Tattoli	officer: SVP, Gen Counsel & Secretary	C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Kwaku Temeng	director	C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002
Gwendolyn Schreffler	officer: SVP	C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Harvey Robert Klingensmith	director	P.O. BOX 131144, HOUSTON TX 77219-1114
Van Dijken Eeuwijk Monique	director	P.O. BOX 129, BILTHOVEN P7 3720 AC
Jan Willem Sodderland	director	DUINDISTEL 89, NOORDWIJK P7 2202 DE
Goldman Sachs Group Inc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Lawrence Bruno	officer: President	6316 WINDFERN ROAD, HOUSTON TX 77040
Mark F Elvig	officer: VP, Counsel & Secretary	6316 WINDFERN, HOUSTON TX 77040
Gregory Barry Barnett	director	853 MILWAUKEE STREET, DENVER CO 80206
Kevin Daniels	officer: CAO & Treasurer	6316 WINDFERN ROAD, HOUSTON TX 77040
Michael Straughen	director	68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN
Martha Z. Carnes	director	6316 WINDFERN ROAD, HOUSTON TX 77040